α-synuclein (SNCA ) but not dynamin 3 (DNM3 ) influences age at onset of leucine-rich repeat kinase 2 (LRRK2) Parkinson's disease in Spain-Reference-Cited by-全球学者库

α-synuclein (SNCA ) but not dynamin 3 (DNM3 ) influences age at onset of leucine-rich repeat kinase 2 (LRRK2) Parkinson's disease in Spain

Published:2018-02-23 Issue:4 Volume:33 Page:637-641
ISSN:0885-3185
Container-title:Movement Disorders
language:en
Short-container-title:Mov Disord.

Author:

Fernández-Santiago Rubén¹²,Garrido Alicia³,Infante Jon²⁴,González-Aramburu Isabel²⁴,Sierra María²⁴,Fernández Manel¹,Valldeoriola Francesc¹²³^ORCID,Muñoz Esteban¹²³,Compta Yaroslau¹²³,Martí María-José¹²³,Ríos José⁵⁶,Tolosa Eduardo¹²³,Ezquerra Mario¹²,

Affiliation:

1. Laboratory of Parkinson Disease and Other Neurodegenerative Movement Disorders, Clinical and Experimental Research, Department of Neurology, Hospital Clínic of Barcelona; Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona; Barcelona Spain

2. Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas; Madrid Spain

3. Movement Disorders Unit, Department of Neurology, Hospital Clínic de Barcelona; Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona; Barcelona Spain

4. Movement Disorders Unit, Department of Neurology; Hospital Universitario Marqués de Valdecilla, Universidad de Cantabria; Santander Spain

5. Medical Statistics Core Facility, Institut d'Investigacions Biomèdiques August Pi i Sunyer and Hospital Clinic; Barcelona Spain

6. Biostatistics Unit, Faculty of Medicine, Universitat Autònoma de Barcelona; Barcelona Spain

Funder

Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas

Jóvenes Investigadores

Spanish Ministry of Economy and Competitiveness (MINECO)

Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED)

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/mds.27295/fullpdf

Reference20 articles.

1. Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study;Healy;Lancet Neurol,2008

2. LRRK2 mutations in Spanish patients with Parkinson disease: frequency, clinical features, and incomplete penetrance;Gaig;Arch Neurol,2006

3. Motor and nonmotor heterogeneity of LRRK2-related and idiopathic Parkinson's disease;Marras;Mov Disord,2016

4. Kin-cohort analysis of LRRK2-G2019S penetrance in Parkinson's disease;Goldwurm;Mov Disord,2011

5. The Gly2019Ser mutation in LRRK2 is not fully penetrant in familial Parkinson's disease: the GenePD study;Latourelle;BMC Med,2008

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetic Modifiers of LRRK2 Parkinson's Disease: A Replication Study in Arab‐Berbers;Movement Disorders;2024-01-31

2. LRRK2 and Parkinson's disease: from genetics to targeted therapy;Annals of Clinical and Translational Neurology;2023-04-06

3. LRRK2: Genetic mechanisms vs genetic subtypes;Handbook of Clinical Neurology;2023

4. What have we learned from genome-wide association studies (GWAS) in Parkinson's disease?;Ageing Research Reviews;2022-08

5. Examples of Inverse Comorbidity between Cancer and Neurodegenerative Diseases: A Possible Role for Noncoding RNA;Cells;2022-06-15